Evaluation of treatment outcomes and factors associated with unsuccessful outcomes in multidrug resistant tuberculosis patients in Baluchistan province of Pakistan

被引:37
|
作者
Khan, Imran [1 ]
Ahmad, Nafees [1 ]
Khan, Shereen [2 ]
Muhammad, Shafi [3 ]
Khan, Shabir Ahmad [4 ]
Ahmad, Izaz [5 ]
Khan, Asad [1 ]
Gulalai [1 ]
Atif, Muhammad [6 ]
机构
[1] Univ Baluchistan Quetta, Fac Pharm & Hlth Sci, Dept Pharm Practice, Quetta, Pakistan
[2] Bolan Med Coll Quetta, Quetta, Pakistan
[3] Univ Baluchistan Quetta, Fac Pharm & Hlth Sci, Dept Pharmacognosy, Quetta, Pakistan
[4] Univ Baluchistan Quetta, Ctr Excellence Vaccinol & Biotechnol, Quetta, Pakistan
[5] Lahore Univ Management Sci, Syed Babar Ali Sch Sci & Engn, Dept Biol, Lahore, Pakistan
[6] Islamia Univ Bahawalpur, Dept Pharm, Bahawalpur, Pakistan
关键词
Baluchistan; Body weight; Death; MDR-TB; Ofloxacin; RISK-FACTORS; PROGRAMMATIC MANAGEMENT; LATENT TUBERCULOSIS; RATES; PREVALENCE; PREDICTORS; DEATH;
D O I
10.1016/j.jiph.2019.04.009
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Evaluating treatment outcomes of a cohort of patients is an effective way for analyzing the effectiveness of a program. Information regarding drug resistance pattern, detailed management, treatment outcomes and factors associated with unsuccessful outcomes in multidrug resistant (MDR-TB) patients is missing from Baluchistan province of Pakistan. Methods This study was carried out at Programmatic Management of Drug Resistant TB unit at Fatimah Jinnah General and Chest Hospital Quetta. All eligible 186 MDR-TB patients enrolled at the study site from January 1, 2012 to April 30, 2016 were retrospectively followed until the treatment outcomes were reported. Data was abstracted through a standardized data collection form and analysed by SPSS 20. Multivariate binary logistic regression (MVBLR) analysis was used to evaluate factors associated with i) death and treatment failure and ii) lost to follow up. A p-value of <0.05 was considered statistically significant. Results The study participants were resistant to a median of four drugs (range 28) with majority being resistant to any second-line anti-TB drug (SLD) (55.5%). Among SLD, resistance was highest for ofloxacin (52.2%). The study site had an overall treatment success rate of 71.6%. A total of 129 (69.4%) patients were cured, four (2.2%) completed treatment, 37 died (19.9%), 14 (7.5%) were lost to follow up and two (1.1%) were declared treatment failures. In MVBLR analysis, patients age of >40 years (OR?=?4.249, p-value?=?0.001) had statistically significant positive and baseline body weight of >40?kg (OR?=?0.256, p-value?=?0.002) had statistically significant negative association with death and treatment failure. No factor had statistical significant association with lost to follow up. Conclusion Overall treatment success rate was promising but did not achieve the target success rate (>75%) set by World Health Organization. It can be further improved by paying special attention and providing enhanced management to the patients with risk factors for unsuccessful outcomes. (C) 2019 The Authors. Published by Elsevier Limited on behalf of King Saud Bin Abdulaziz University for Health Sciences. This is an open access article under the CC BY-NC-ND license (http://creativecommons.orgg/licensesiby-nc-nd/4.0/).
引用
收藏
页码:809 / 815
页数:7
相关论文
共 50 条
  • [41] Treatment outcomes in patients with multidrug-resistant tuberculosis in Japan, 2011-2013
    Kobayashi, Nobuyuki
    Hattori, Toshio
    Akter, Shamima
    Mizoue, Tetsuya
    Ohta, Ken
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [42] Treatment outcomes of patients with multidrug and extensively drug-resistant tuberculosis in Zhejiang, China
    Ming-Wu Zhang
    Lin Zhou
    Yu Zhang
    Bin Chen
    Ying Peng
    Fei Wang
    Zheng-Wei Liu
    Xiao-Meng Wang
    Song-Hua Chen
    European Journal of Medical Research, 26
  • [43] Treatment outcomes in patients with multidrug-resistant tuberculosis in north-west Ethiopia
    Alene, Kefyalew Addis
    Viney, Kerri
    McBryde, Emma S.
    Tsegaye, Adino Tesfahun
    Clements, Archie C. A.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2017, 22 (03) : 351 - 362
  • [44] Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis: Concern to Bedaquiline: Authors' Reply
    Kang, Yewon
    Mok, Jeongha
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2022, 85 (01) : 98 - 99
  • [45] Treatment Outcomes of Pulmonary Pyrazinamide-Resistant Multidrug-Resistant Tuberculosis
    Park, S.
    Ji, W.
    Jo, K.
    Shim, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [46] Predictors of unsuccessful tuberculosis treatment outcomes in children from a prospective cohort study in Pakistan
    Brooks, Meredith B.
    Malik, Amyn
    Khan, Salman
    Ahmed, Junaid F.
    Siddiqui, Sara
    Jaswal, Maria
    Saleem, Saniya
    Amanullah, Farhana
    Becerra, Mercedes C.
    Hussain, Hamidah
    JOURNAL OF GLOBAL HEALTH, 2021, 11 : 1 - 8
  • [47] Risk factors for poor multidrug-resistant tuberculosis treatment outcomes in Kyiv Oblast, Ukraine
    Omowunmi Aibana
    Mariya Bachmaha
    Viatcheslav Krasiuk
    Natasha Rybak
    Timothy P. Flanigan
    Vasyl Petrenko
    Megan B. Murray
    BMC Infectious Diseases, 17
  • [48] Risk factors for poor multidrug-resistant tuberculosis treatment outcomes in Kyiv Oblast, Ukraine
    Aibana, Omowunmi
    Bachmaha, Mariya
    Krasiuk, Viatcheslav
    Rybak, Natasha
    Flanigan, Timothy P.
    Petrenko, Vasyl
    Murray, Megan B.
    BMC INFECTIOUS DISEASES, 2017, 17
  • [49] Treatment outcomes among childhood extensively drug-resistant tuberculosis patients in Pakistan
    Abubakar, Muhammad
    Ahmad, Nafees
    Atif, Muhammad
    Khan, Amer Hayat
    Ghafoor, Abdul
    ERJ OPEN RESEARCH, 2022, 8 (01)
  • [50] Treatment outcomes and associated factors among patients with multidrug-resistant tuberculosis in Ashanti Region, Ghana: a retrospective, cross-sectional study
    Panford, Victoria
    Kumah, Emmanuel
    Kokuro, Collins
    Adoma, Prince Owusu
    Baidoo, Michael Afari
    Fusheini, Adam
    Ankomah, Samuel Egyakwa
    Agyei, Samuel Kofi
    Agyei-Baffour, Peter
    BMJ OPEN, 2022, 12 (07):